Search:

Home Index Back issues Contact

 

Volume 20, Number 1

 

Oxygen therapy in acute exacerbations of COPD

Alan Fletcher MRCP FFAEM Specialist Registrar in Emergency Medicine and General Medicine, Northern General Hospital, Sheffield

Most of us can recall a teaching session as an undergraduate or junior doctor in which the danger of oxygen for patients with chronic obstructive pulmonary disease (COPD) was explained in gripping fashion. Suddenly, the gas that we considered life-saving was revealed as a potential sinister killer.

 

Diving and lung disease – principles and implications

Graeme P Currie MD DCH MRCP Specialist Registrar in Respiratory Medicine, Aberdeen Royal Infirmary, Aberdeen; David J Godden MD FRCPE FRCPG Director, Highlands and Islands Health Research Institute, University of Aberdeen, Inverness

Underwater diving as a recreational pursuit is becoming increasingly popular. Medical practitioners may face requests to evaluate and treat frequently encountered diving-related illness and injury and to advise on aspects of fitness to dive.

 

Respiratory epidemics: a review of 2004

Philip Ind, Editor

2004 is a year of respiratory epidemics and the impact of respiratory disease on the nation’s health is detailed in Lung Report III – Casting a shadow over the nation’s health1 from the British Lung Foundation; it is all about epidemics.

 

New developments with Streptococcus pneumoniae

Jim Catterall BSc MD FRCP Consultant Physician, Bristol Royal Infirmary, Bristol

Most cases of community-acquired pneumonia are caused by Streptococcus pneumoniae. Bacteraemic pneumococcal pneumonia still has a mortality rate of 7–35%.

 

Imaging in the diagnosis of pulmonary thromboembolism – current perspectives

Edwin JR van Beek MD PhD FRCR Reader in Radiology/Honorary Consultant in Radiology; Eleanor Lorenz MB ChB FRCR Consultant Radiologist, Unit of Academic Radiology and Department of Radiology, Royal Hallamshire Hospital, Sheffield

Pulmonary embolism is now recognised as part of the spectrum of venous thromboembolic disorders. Pulmonary thromboembolism (PE) is a major cause of morbidity and mortality, with an annual incidence in the Western world around 0.5 per 1,000.1

 

 


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Respiratory Disease in Practice is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk